ClinicalTrials.Veeva

Menu

Noninvasive Diagnostic Techniques in Determination of Site of Lesion of Auditory Neuropathy Spectrum Disorder

S

Sohag University

Status

Enrolling

Conditions

Auditory Neuropathy

Treatments

Diagnostic Test: extratympanic electrocochleograhy

Study type

Observational

Funder types

Other

Identifiers

NCT05666466
Soh-Med-22-12-16

Details and patient eligibility

About

cross-sectional study of population who have ANSD

Full description

Cross-sectional nonivasive study including study and control group aiming to determine site of lesion of auditory neuropathy spectrum disorder either presynaptic or postsynaptic by using electrophysiological measures

Enrollment

25 estimated patients

Sex

All

Ages

12 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age between 12 and 50 years OAE and CM could be present disproportionate SRS to PTA level

Exclusion criteria

proportionate ABR to PTA level Proportionate SRS to PTA level

  • presnce ol lesions in CT or MRI

Trial design

25 participants in 2 patient groups

case group
Description:
age between 12 to 50 disproportionate SRS to PTA level presence of OAE presence of CM Normal MRI and CT
Treatment:
Diagnostic Test: extratympanic electrocochleograhy
control group
Description:
age and sex matched to study group Normal hearing sensitivity and excellent speech discrimination no CAPD
Treatment:
Diagnostic Test: extratympanic electrocochleograhy

Trial contacts and locations

1

Loading...

Central trial contact

Rania Khalil, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems